cuppa tee
Well-Known Member
I always slather on a generous amount before I grab the handle of a shopping basket.
could be wrong but after might be better.
I always slather on a generous amount before I grab the handle of a shopping basket.
I do it instead of wiping down the handle - and I always scrub up when I get home and I quarantine the shopping for a bit ...could be wrong but after might be better.
I don't think it is possible to take an individual case and prove transmission by a particular means. I believe the consensus is that you can catch Covid from surfaces, but that is likely to represent a small minority of cases.Has there been any proven transmission via surfaces at all yet?
I'm also concerned that a legacy of this pandemic will be a residual germophobia. We used to view it as a sign of concern for people to constantly sanitise their hands, that this indicated an obsessive concern about an excessively magnified risk, making it difficult for people to live their lives. I wonder about the long-term effect of normalising this.Hand sanitiser everywhere annoys me a little now as its main purpose seems to be to allow people to feel as if they are doing something meaningful whilst completely ignoring ventilation.
I'm also concerned that a legacy of this pandemic will be a residual germophobia. We used to view it as a sign of concern for people to constantly sanitise their hands, that this indicated an obsessive concern about an excessively magnified risk, making it difficult for people to live their lives. I wonder about the long-term effect of normalising this.
Has there been any proven transmission via surfaces at all yet?
Thought for the day:
The work by the London School of Hygiene and Tropical Medicine is not a crystal ball. It does not say what will happen with Omicron but gives a range of possible outcomes.
In the most optimistic scenario the numbers being admitted to hospitals every day would be 40% lower than the peak last winter. In the most pessimistic scenario it would be nearly twice as high.
But the report said "the majority of scenarios" concluded that with current measures there would be more admissions than last winter.
Dr Davies said: "I think our projections are worrying, it doesn't paint an optimistic picture."
In the most optimistic scenario the numbers being admitted to hospitals every day would be 40% lower than the peak last winter. In the most pessimistic scenario it would be nearly twice as high.
But the report said "the majority of scenarios" concluded that with current measures there would be more admissions than last winter.
Dr Davies said: "I think our projections are worrying, it doesn't paint an optimistic picture."
What would you have them do differently? I recall from the past that you didnt like the vaccine assumptions used, and its fair enough to debate what the realistic parameters for those should be. But when it comes to whether the model itself is pessimistic, I note that they do try to test and adjust their model via things like fitting their model to real data observed in the past (and there are graphs of them doing that in this latest document, using real data from the entire pandemic so far).
Is it not more the case that prrdictions were made for what would happen without restrictions, restrictions were then put in in a half baked way, and we never got to see what would have actually happened without them.Previous such scenarios and projections for alpha turned out to be wildly inaccurate, with the more transmissible delta wave that came along delivering fewer hospitalizations than even the most optimistic of scenarios modeled for alpha. So when someone says "even in the most optimistic scenario" it should really be read as "in our most optimistic scenario, from our pessimistic model"
I was going to mention their vaccine efficacy figures for hospitalisation and death (falling to 66% for the unboosted in the most optimistic of the two scenerios) in Table 1. These seem to be plucked from thin air, but I wasn't sure it worth arguing on here.
Neutralisation studies on Omicron are ongoing, so we rely on a combination of estimates of the fold reduction in neutralisation titre for previous variants of concern (VOCs) as well as early studies explicitly considering Omicron neutralisation (1–5) to inform our assumptions about the level of immune escape Omicron might possess. The largest drop in neutralisation titre (8.8 fold) was estimated for the Beta VOC (20), with a 3.9 fold reduction for the Delta variant, compared to the ancestral SARS-CoV-2 virus. We consider two scenarios for the immune escape of Omicron relative to Delta: 5.1-fold (escape low, EL) and 12.8-fold (escape high, EH) reductions compared to our existing assumptions for Delta (19). Since the Delta variant was estimated to have a 3.9 fold reduction in neutralisation compared to the ancestral SARS-CoV-2 virus, these assumptions correspond to overall fold reductions of approximately 20 and 50-fold between the ancestral SARS-CoV-2 virus and the Omicron variant.
We use the relationship between mean neutralisation titre and protective efficacy from Khoury et al. (7) to arrive at assumptions for vaccine efficacy against infection with Omicron, given each drop in neutralisation. We then use Khoury et al.’s modelled relationship between efficacy against any infection and efficacy against severe infection to generate vaccine effectiveness estimates against severe outcomes (Fig. 1c). For the effectiveness of booster vaccinations against Omicron, we base two main scenarios on two studies which measured increases in neutralisation titres following the second dose of the primary vaccination course and after booster vaccinations with the Moderna (2.5-fold) and Sinovac (4.9-fold) vaccines (20). We assume that protection against infection for individuals who have received a primary course of the AstraZeneca COVID-19 vaccine before being boosted with either full-dose Pfizer or half-dose Moderna (the current policy in England) is initially increased to the same levels as Pfizer/Moderna, before using the relationship in Fig. 1c to scale protection against infection to protection against severe outcomes (hospitalisation and death). We assume that individuals in the recovered disease state who have previously been infected with SARS-CoV-2 have the same level of protection against Omicron as individuals who have received two doses of Pfizer/Moderna. Our estimates for vaccine protection against different outcomes for the Delta variant and for the various Omicron scenarios are shown in Table 1.
I have mentioned in other posts some acknowledged limitations with the UKHSA AZ estimates that they mention in that last bit, so I'm not surprised they have used higher ones for that.These estimates are broadly in line with early vaccine effectiveness estimates against Omicron and Delta from the UK’s Health Security Agency (21), with the exception that our assumptions for dose 2 AstraZeneca vaccine protection against Omicron disease are high in comparison (we assume 38.2% and 23.3% protection against disease, whereas the UKHSA study’s highest estimate for protection against Omicron disease with two doses of AstraZeneca is 5.9%).
Is it not more the case that prrdictions were made for what would happen without restrictions, restrictions were then put in in a half baked way, and we never got to see what would have actually happened without them.
before using the relationship in Fig. 1c to scale protection against infection to protection against severe outcomes (hospitalisation and death).
Its what uncertain science looks like, have you got a better methodology they could use instead? Would you rather they pluck optimistic stuff from thin air instead? And this isnt SAGE, although obviously they are one of the sources SAGE relies on and there is overlap between people in the academic institutions and members of SAGE.
Please do dig the old stuff out, so we can evaluate your criticisms of past modelling.
I'll do it myself then when I find time. I expect I'll be able to build a case that you are misrepresenting the limitations of past modelling in order to serve your dubious agenda.No. Last time I did something like that you said "I am not interested in playing this stupid game with you" so I'll try and stick to reddit for that stuff.
But yes, I'd have nothing against a larger number of scenarios being presented in modelling reports. Including more optimistic ones. But then it comes down to what some people will want build off the back of more optimistic scenarios being presented at this time. An excuse to do less at this stage? That carries its own risk, better safe than sorry is a reasonable approach given the stakes.